Advertisement Mylan Pharma introduces schizophrenia drug - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Mylan Pharma introduces schizophrenia drug

Mylan Pharmaceuticals, a subsidiary of Mylan Inc, has introduced Risperidone Orally Disintegrating Tablets (ODT), 0.5mg, 1mg, 2mg, 3mg and 4mg.

Risperidone Orally Disintegrating Tablets are an atypical antipsychotic that work by affecting certain substances in the brain.

Risperidone Orally Disintegrating Tablets 0.5mg, 1mg, 2mg, 3mg and 4mg are the generic version of Ortho-McNeil’s Risperdal M-Tab, indicated for the treatment of schizophrenia.